Healthcare · Medical - Devices
Price
$0.72
Market Cap
$32.3M
Employees
217
Beta
1.31
Avg Volume
177,054
CEO
Antony Koblish
Business Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Business History
Price Overview
Price at report time · Jul 4, 2:45pm (0m ago)
$0.72
Change · Jul 4
+0.00 (+0.19%)
Day Range
$0.72 – $0.74
52-Week Range
$0.50 – $2.20
50-Day MA
$0.87
200-Day MA
$1.02
Volume
14,470.00
Right now · live
loading…
Real-time — the change above is the move since the report (over 0m).
Analyst Price Targets
Low
$1.25
Consensus
$8.25
High
$20.00
(9 analysts)
Share Structure
Outstanding
44,766,146.00
Float
32,911,230.00
Free Float
73.5%
Normal free float
— 73.5% of shares trade freely, ~26.5% held by insiders/institutions
Healthy float typical of established companies. Good liquidity for entering and exiting positions without major price impact.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-0.87
Stock Price: $0.72
EPS (Diluted): -0.83
EPS (Diluted): -0.83
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
8.78
Stock Price: $0.72
Total Equity: $6.31M
Shares: 46,947,932
Total Equity: $6.31M
Shares: 46,947,932
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-1.51
Market Cap: $32.29M
Total Debt: $55.65M
Cash: $50.85M
EBITDA: -$32.35M
Total Debt: $55.65M
Cash: $50.85M
EBITDA: -$32.35M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$60.2M
Market Cap: $32.29M
Total Debt: $55.65M
Cash: $50.85M
Total Debt: $55.65M
Cash: $50.85M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
0.69
Stock Price: $0.72
Revenue: $80.28M
Shares: 46,947,932
Revenue: $80.28M
Shares: 46,947,932
EV/Sales (Total value vs revenue — works when P/E can't)
API0.75
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
67.7%
Gross Profit: $54.34M
Revenue: $80.28M
Revenue: $80.28M
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
-42.0%
Operating Income: -$33.76M
Revenue: $80.28M
Revenue: $80.28M
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
-48.4%
Net Income: -$38.83M
Revenue: $80.28M
Revenue: $80.28M
ROE (Profit from shareholder equity)
APINet Income / Total Equity
-1,344.5%
Net Income: -$38.83M
Total Equity: $6.31M
Total Equity: $6.31M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
-64.3%
Operating Income: -$33.76M
Tax Rate: -0.6%
Equity: $6.31M
Total Debt: $55.65M
Cash: $50.85M
Tax Rate: -0.6%
Equity: $6.31M
Total Debt: $55.65M
Cash: $50.85M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
4.20
Current Assets: $75.58M
Current Liabilities: $17.98M
Current Liabilities: $17.98M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
8.82
Short-Term Debt: $0.00
Long-Term Debt: $55.65M
Total Debt: $55.65M
Total Equity: $6.31M
Long-Term Debt: $55.65M
Total Debt: $55.65M
Total Equity: $6.31M
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$1.71
Revenue: $80.28M
Shares: 46,947,932
Shares: 46,947,932
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$0.13
Total Equity: $6.31M
Shares: 46,947,932
Shares: 46,947,932
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-0.61
Operating CF: -$28.22M
CapEx: -$448,000
Shares: 46,947,932
CapEx: -$448,000
Shares: 46,947,932
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $0.72
Stock Price: $0.72
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$38.83M
Net Income: -$38.83M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares TELA against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jul 4, 2026 2:45pm (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $29.5M | $41.4M | $58.5M | $69.3M | $80.3M |
| Cost of Revenue | $10.7M | $14.4M | $18.3M | $22.8M | $25.9M |
| Gross Profit | $18.8M | $27.0M | $40.1M | $46.5M | $54.3M |
| Operating Expenses | $48.3M | $66.1M | $84.2M | $80.6M | $88.1M |
| Operating Income | -$29.5M | -$39.0M | -$44.1M | -$34.1M | -$33.8M |
| Net Income | -$33.3M | -$44.3M | -$46.7M | -$37.8M | -$38.8M |
| EBITDA | -$29.1M | -$39.1M | -$40.6M | -$31.7M | -$32.3M |
| EPS | $-2.30 | $-2.73 | $-2.04 | $-1.33 | $-0.83 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jul 4, 2026 2:45pm (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $43.9M | $42.0M | $46.7M | $52.7M | $50.8M |
| Total Current Assets | $59.1M | $62.4M | $71.7M | $78.1M | $75.6M |
| Total Assets | $62.5M | $67.9M | $78.0M | $87.3M | $81.4M |
| Current Liabilities | $10.6M | $12.4M | $17.0M | $15.6M | $18.0M |
| Long-Term Debt | $31.5M | $39.9M | $40.5M | $41.1M | $55.7M |
| Total Liabilities | $42.4M | $53.6M | $59.2M | $58.9M | $75.1M |
| Total Equity | $20.1M | $14.3M | $18.9M | $28.5M | $6.3M |
| Retained Earnings | -$229.9M | -$274.2M | -$320.9M | -$358.7M | -$397.6M |
Cash Flow (Annual)
Last updated: Jul 4, 2026 2:45pm (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$30.4M | -$40.7M | -$40.9M | -$41.6M | -$28.2M |
| Capital Expenditure | $-627,000 | -$1.9M | $-611,000 | $-989,000 | $-448,000 |
| Free Cash Flow | -$31.1M | -$42.6M | -$41.5M | -$42.6M | -$28.7M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | $1.3M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $105,000 |
| Net Change in Cash | -$30.5M | -$1.9M | $5.0M | $5.9M | -$1.8M |
Analyst Estimates (Annual)
Last updated: Jul 4, 2026 2:45pm (just now)| Metric | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Revenue |
$80.4M $80.2M – $80.7M
|
$86.7M $86.4M – $87.0M
|
$95.7M $95.4M – $96.0M
|
$106.8M $106.8M – $106.8M
|
| EBITDA |
$11.5M $11.5M – $11.5M
|
$12.4M $12.4M – $12.4M
|
$13.7M $13.7M – $13.7M
|
$15.3M $15.3M – $15.3M
|
| Net Income |
-$38.4M -$38.6M – -$38.2M
|
-$30.7M -$30.8M – -$30.6M
|
-$25.2M -$25.3M – -$25.1M
|
-$18.3M -$18.3M – -$18.2M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jul 4, 2026 2:45pm (just now)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +40.6% | +41.1% | +18.6% | +15.8% |
| Gross Profit Growth | +43.8% | +48.3% | +15.9% | +16.9% |
| Operating Income Growth | -32.4% | -13.0% | +22.6% | +1.1% |
| Net Income Growth | -33.1% | -5.3% | +18.9% | -2.6% |
| EBITDA Growth | -34.0% | -4.0% | +22.0% | -2.1% |
Insider Trading (Recent)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-09 | Rocchio Betty Jo | A-Award | 11,675.00 | $0.00 | $0 |
| 2026-06-09 | Rocchio Betty Jo | A-Award | 17,335.00 | $0.94 | $16,208 |
| 2026-06-09 | Capper Joseph H | A-Award | 11,675.00 | $0.00 | $0 |
| 2026-06-09 | Capper Joseph H | A-Award | 17,550.00 | $0.94 | $16,409 |
| 2026-06-09 | Capper Joseph H | A-Award | 17,335.00 | $0.94 | $16,208 |
| 2026-06-09 | Capper Joseph H | A-Award | 11,925.00 | $0.00 | $0 |
| 2026-06-09 | Capper Joseph H | 0.00 | $0.00 | $0 | |
| 2026-06-09 | Plovanic William J. | A-Award | 11,675.00 | $0.00 | $0 |
| 2026-06-09 | Plovanic William J. | A-Award | 17,335.00 | $0.94 | $16,208 |
| 2026-06-09 | NEELS GUIDO J | 0.00 | $0.00 | $0 | |
| 2026-06-09 | NEELS GUIDO J | A-Award | 11,675.00 | $0.00 | $0 |
| 2026-06-09 | NEELS GUIDO J | A-Award | 17,550.00 | $0.94 | $16,409 |
| 2026-06-09 | NEELS GUIDO J | A-Award | 17,335.00 | $0.94 | $16,208 |
| 2026-06-09 | NEELS GUIDO J | A-Award | 11,925.00 | $0.00 | $0 |
| 2026-06-09 | THOMAS PAUL | 0.00 | $0.00 | $0 | |
| 2026-06-09 | THOMAS PAUL | A-Award | 11,675.00 | $0.00 | $0 |
| 2026-06-09 | THOMAS PAUL | A-Award | 17,550.00 | $0.94 | $16,409 |
| 2026-06-09 | THOMAS PAUL | A-Award | 17,335.00 | $0.94 | $16,208 |
| 2026-06-09 | THOMAS PAUL | A-Award | 11,925.00 | $0.00 | $0 |
| 2026-06-09 | NOHRA GUY P | 0.00 | $0.00 | $0 |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for TELA — it's generated by the pipeline (
market-narrative step).
No community reviews yet for TELA.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.377 · 1648bd22 · 2026-07-04 14:36:23